The possible removal of the headcount test should dramatically change the outcome of this transaction. I'd buy here, and buy up to ~$2.75/share or 2.5%/~15% gross/annualised.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.